Pharming Group N.V (PHAR) Share-based Compensation: 2020-2023
- Pharming Group N.V's Share-based Compensation was N/A to $4.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $8.0 million, marking a year-over-year change of. This contributed to the annual value of $9,036 for FY2021, which is 99.86% down from last year.
- As of Q2 2023, Pharming Group N.V's Share-based Compensation stood at $4.0 million, which was up 271.03% from $1.1 million recorded in Q4 2022.
- In the past 5 years, Pharming Group N.V's Share-based Compensation registered a high of $4.2 million during Q4 2020, and its lowest value of -$3.7 million during Q3 2021.
- For the 3-year period, Pharming Group N.V's Share-based Compensation averaged around $862,916, with its median value being $1.1 million (2022).
- Data for Pharming Group N.V's Share-based Compensation shows a maximum YoY plummeted of 548.57% (in 2021) over the last 5 years.
- Quarterly analysis of 4 years shows Pharming Group N.V's Share-based Compensation stood at $4.2 million in 2020, then tumbled by 54.24% to $1.9 million in 2021, then crashed by 43.95% to $1.1 million in 2022, then reached $4.0 million in 2023.
- Its last three reported values are $4.0 million in Q2 2023, $1.1 million for Q4 2022, and $1.1 million during Q1 2022.
